NDC 86052-010-01 - Protomor
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86052-010
- Requested NDC
- 86052-010-01
- Package NDCs from labels
- 86052-010-01, 86052-010-02
- Manufacturer
- Aquarium Muenster Pahlsmeier GmbH | Sigma-Aldrich Production GMBH | Merck KGaA
- Effective date
- 2024-04-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Protomor | Aquarium Muenster Pahlsmeier GmbH | Sigma-Aldrich Production GMBH | Merck KGaA | 2024-04-19 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86052-010-01 | Protomor | 20 mL in 1 BOTTLE, GLASS | SOLUTION | 20 | 8 | |
| 86052-010-01 | Protomor | 1 in 1 CARTON | SOLUTION | 1 | 8 | |
| 86052-010-02 | Protomor | 100 mL in 1 BOTTLE, GLASS | SOLUTION | 100 | 8 | |
| 86052-010-02 | Protomor | 1 in 1 CARTON | SOLUTION | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 86052-010 | PROTOMOR (MALACHITE GREEN OXALATE, ETHACRIDINE LACTATE, METHYLENE BLUE ANHYDROUS, GENTIAN VIOLET) SOLUTION [AQUARIUM MUENSTER PAHLSMEIER GMBH] | 8 | 4 package rows | 20240428_345606b0-2521-4822-9dcd-054ac7077ea1.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentian Violet | GENTIAN VIOLET | Vitamex USA, Corp | 21742061-fc0b-f750-e063-6394a90a7508 | 2026-08-26 | Warnings | J4Z741D6O5 |
| Humco Gentian Violet 1% | GENTIAN VIOLET 1% | Humco Holding Group, Inc. | 7b4e6572-cb44-491d-8063-f7519307a8e5 | 2026-07-09 | Warnings | J4Z741D6O5 |
| Gentian Violet 1% | GENTIAN VIOLET 1% | Pharma Nobis, LLC | e42fa7d2-47ef-0e82-e053-2995a90a67c5 | 2026-07-09 | Warnings | J4Z741D6O5 |
| Humco Gentian Violet 2% | GENTIAN VIOLET 2% | Humco Holding Group, Inc. | a07f61e5-0215-419a-a68a-1d814417c35f | 2026-07-09 | Warnings | J4Z741D6O5 |
| GNP Gentian Violet 1% | GENTIAN VIOLET 1% | Amerrisource Bergen | 5d07274f-e848-6c60-e053-2991aa0a40d8 | 2026-07-09 | Warnings | J4Z741D6O5 |
| El Valle Gentian Violet | GENTIAN VIOLET 1% | Pharmadel LLC | fc75aa2b-0e6e-e2f7-e053-6294a90ac01f | 2026-04-13 | Warnings | J4Z741D6O5 |
| Gentian Violet 2% | GENTIAN VIOLET 2% | The Podiatree Company | 60ba9bb0-cc7a-1ccf-e053-2a91aa0ac4b8 | 2026-01-08 | Warnings | J4Z741D6O5 |
| Me NaPhos MB Hyo 1 | URINARY ANTISEPTIC ANTISPASMODIC | Method Pharmaceuticals | 2ae628e7-3b33-6a9a-e054-00144ff8d46c | 2025-10-21 | Warnings, Adverse reactions | 8NAP7826UB |
| Gentian Violet | GENTIAN VIOLET | World Perfumes Inc | 419cc9a2-bfde-a516-e063-6294a90a065c | 2025-10-20 | Warnings | J4Z741D6O5 |
| DE LA CRUZ GENTIAN VIOLET | GENTIAN VIOLET | DLC Laboratories, Inc. | d7b4ca59-1bc3-4540-bc0a-2f4b7495a0a7 | 2024-12-30 | Warnings | J4Z741D6O5 |
| Sanar Naturals Gentian Violet | GENTIAN VIOLET | Sanvall Enterprises, Inc | 1922518d-e49b-5010-e063-6394a90a9112 | 2024-10-31 | Warnings | J4Z741D6O5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.